Melatonin reduces glial reactivity in the hippocampus, cortex, and cerebellum of streptozotocin-induced diabetic rats

Free Radical Biology and Medicine

Volumn 35, Issue 7, 2003, Pages 797-804

  Baydas, Giyasettin ^a   Reiter, Russel J ^b   Yasar, Abdullah ^a   Tuzcu, Mehmet ^a   Akdemir, Ismail ^a   Nedzvetskii, Viktor S ^c  

^a FIRAT UNIVERSITY   (Turkey)

^b UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^c OLES HONCHAR DNIPRO NATIONAL UNIVERSITY   (Ukraine)

Author keywords

Cerebellum; Cortex; Diabetes; Free radicals; Glial fibrillary acidic protein; Hippocampus; Lipid peroxidation; Melatonin; S100B; Streptozotocin

Indexed keywords

BIOLOGICAL MARKER; GLIAL FIBRILLARY ACIDIC PROTEIN; MELATONIN; PROTEIN S100B; STREPTOZOCIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTROCYTE; BRAIN CORTEX; BRAIN REGION; CELL ACTIVATION; CEREBELLUM; CONTROLLED STUDY; DIABETES MELLITUS; DOWN REGULATION; GLIA CELL; HIPPOCAMPUS; HORMONAL REGULATION; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; LIPID PEROXIDATION; MALE; NEUROMODULATION; NEUROPATHOLOGY; NONHUMAN; PRIORITY JOURNAL; RAT; STATISTICAL SIGNIFICANCE; UPREGULATION; WESTERN BLOTTING;

EID: 0142258702     PISSN: 08915849     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0891-5849(03)00408-8     Document Type: Article

References (54)

1. Gispen W.H., Biessels G.J. Cognition and synaptic plasticity in diabetes mellitus. Trends Neurosci. 23:2000;542-549.
2. McCall A.L. The impact of diabetes on the CNS. Diabetes. 41:1992;557-570.
3. Biessels G.J., Kapessa A.C., Bravenboer B., Erkelens D.W., Gispen W.H. Cerebral function in diabetes mellitus. Diabetologia. 37:1994;643-650.
4. Bresnick G.H. Diabetic retinopathy viewed as a neurosensory disorder. Arch. Ophthalmol. 104:1986;989-990.
5. Greene D.A., Stevens M.J., Obrosova I., Feldman E.L. Glucose-induced oxidative stress and programmed cell death in diabetic neuropathy. Eur. J. Pharmacol. 375:1999;217-223.
6. Low P.A., Nickander K.K., Tritschler H.J. The role of oxidative stress and antioxidant treatment in experimental diabetic neuropathy. Diabetes. 46:1997;S38-42.
7. Zaltzberg H., Kanter Y., Aviram M., Levy Y. Increased plasma oxidizability and decreased erythrocyte and plasma antioxidative capacity in patients with NIDDM. Isr. Med. Assoc. J. 1:1999;228-231.
8. Baydas G., Canatan H., Turkoglu A. Comparative analyses of the protective effects of melatonin and vitamin E on streptozocin-induced diabetes mellitus. J. Pineal Res. 32:2002;225-229.
9. Celik S., Baydas G., Yilmaz O. Influence of vitamin E on the levels of fatty acids and MDA in some tissues of diabetic rats. Cell Biochem. Funct. 20:2002;67-71.
10. Montgomery D.L. Astrocytes form, functions, and roles in disease . Vet. Pathol. 31:1994;145-167.
11. Lamigeon C., Bellier J.P., Sacchettoni S., Rujano M., Jacquemont B. Enhanced neuronal protection from oxidative stress by coculture with glutamic acid decarboxylase-expressing astrocytes. J. Neurochem. 77:2001;598-606.
12. Aschner M. Neuron-astrocyte interactions implications for cellular energetics and antioxidant levels . Neurotoxicology. 21:2000;1101-1107.
13. Drukarch B., Schepens E., Stoof J.C., Langeveld C.H., Van Muiswinkel F.L. Astrocyte-enhanced neuronal survival is mediated by scavenging of extracellular reactive oxygen species. Free Radic. Biol. Med. 25:1998;217-220.
14. Kunkler P.E., Kraig R.P. Reactive astrocytosis from excitotoxic injury in hippocampal organ culture parallels that seen in vivo. J. Cereb. Blood Flow Metab. 17:1997;26-43.
15. Kaneko K., Nakamura A., Yoshida K., Kametani F., Higuchi K., Ikeda S. Glial fibrillary acidic protein is greatly modified by oxidative stress in aceruloplasminemia brain. Free Radic. Res. 36:2002;303-306.
16. Norton W.T., Aquino D.A., Hozumi I., Chiu F.C., Brosnan C.F. Quantitative aspects of reactive gliosis a review . Neurochem. Res. 17:1992;877-885.
17. Cerutti S.M., Chadi G. S100 immunoreactivity is increased in reactive astrocytes of the visual pathways following a mechanical lesion of the rat occipital cortex. Cell Biol. Int. 24:2000;35-49.
18. Marshak D.R., Pesce S.A., Stanley L.C., Griffin W.S. Increased S100 neurotrophic activity in Alzheimer disease temporal lobe. Neurobiol. Aging. 13:1992;1-7.
19. Bhattacharyya A., Oppenheim R.W., Prevette D., Moore B.W., Brackenbury R., Ratner N. S100 is present in developing chicken neurones, and Schwann cells, and promotes neuron survival in vivo. J. Neurobiol. 23:1992;451-466.
20. Moosmann B., Behl C. Antioxidants as treatment for neurodegenerative disorders. Expert Opin. Investig. Drugs. 11:2002;1407-1435.
21. Tan D.X., Chen L.D., Poeggeler B., Manchester L.C., Reiter R.J. Melatonin a potent, endogenous hydroxyl radical scavenger . Endocrine J. 1:1993;57-60.
22. Reiter R.J. Oxidative damage in the central nervous system protection by melatonin . Prog. Neurobiol. 56:1998;359-384.
23. Reiter R.J., Acuña-Castroviejo D., Tan D.X., Burkhardt S. Free radical-mediated molecular damage. Mechanisms for the protective actions of melatonin in the central nervous system. Ann. N.Y. Acad. Sci. 939:2001;200-215.
24. Tan D.X., Manchester L.C., Hardeland R., Lopez-Burillo S., Mayo J.C., Sainz R.M., Reiter R.J. Melatonin a hormone, a tissue factor, an autocoid, a paracoid, and an antioxidant . J. Pineal Res. 34:2003;75-78.
25. Zhang H., Squadrito G.L., Pryor W.A. The reaction of melatonin with peroxynitrite formation of melatonin radical cation and absence of stable nitrated products . Biochem. Biophys. Res. Commun. 251:1998;83-87.
26. Allegra M., Reiter R.J., Tan D.X., Gentile C., Tesoriere L., Livrea M.A. The chemistry of melatonin's interaction with reactive species. J. Pineal Res. 34:2003;1-10.
27. Baydas G., Ercel E., Canatan H., Donder E., Akyol A. Effect of melatonin on oxidative status of rat brain, liver and kidney tissues under constant light exposure. Cell Biochem. Funct. 19:2001;37-41.
28. Baydas G., Kutlu S., Naziroglu M., Canpolat S., Sandal S., Ozcan M., Kelestimur H. Inhibitory effects of melatonin on neural lipid peroxidation induced by intracerebroventricularly administered homocysteine. J. Pineal Res. 34:2003;36-39.
29. Chung S.Y., Han S.H. Melatonin attenuates kainic acid-induced hippocampal neurodegeneration and oxidative stress through microglial inhibition. J. Pineal Res. 34:2003;95-102.
30. 2-generated lipid peroxides in tissue homogenates. Res. Comm. Pharmacol. Toxicol. 6:2001;287-295.
31. Borlongan C.V., Yamamoto M., Takei N., Kumazaki M., Ungsuparkorn C., Hida H., Sanberg P.R., Nishino H. Glial cell survival is enhanced during melatonin-induced neuroprotection against cerebral ischemia. FASEB J. 14:2000;1307-1317.
32. Baydas G., Reiter R.J., Nedzvetskii V.S., Nerush P.A., Kirichenko S.V. Altered glial fibrillary acidic protein content and its degradation in the hippocampus, cortex and cerebellum of rats exposed to constant light reversal by melatonin . J. Pineal Res. 33:2002;134-139.
33. Reiter R.J., Tan D.X. What constitutes a physiological concentration of melatonin? J. Pineal Res. 34:2003;79-80.
34. Laemmli U.K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 227:1970;680-685.
35. Ellman G.L. Tissue sulphydryl groups. Arch. Biochem. Biophys. 82:1959;70-77.
36. Sano T., Umeda F., Hashimoto T., Nowata H., Utsumi H. Oxidative stress measurement by in vivo electron spin resonance spectroscopy in rats with streptozotocin-induced diabetes. Diabetologia. 41:1998;1355-1360.
37. Hawkins C.L., Davies M.J. Generation and propagation of radical reactions on proteins. Biochem. Biophys. Acta. 1504:2001;196-219.
38. Luxford C., Dean R.T., Davies M.J. Radicals derived from histone hydro peroxides damage nucleobases in RNA and DNA. Chem. Res. Toxicol. 13:2000;665-672.
39. Tachi Y., Okuda Y., Bannai C., Bannai S., Shinohara M., Shimpuku H., Yamashita K., Ohura K. Hyperglycemia in diabetic rats reduces the glutathione content in the aortic tissue. Life Sci. 69:2001;1039-1047.
40. Dincer Y., Akcay T., Alademir Z., Ilkova H. Effect of oxidative stress on glutathione pathway in red blood cells from patients with insulin-dependent diabetes mellitus. Metabolism. 51:2002;1360-1362.
41. Urata Y., Honma S., Goto S., Iada T., Cho S., Honma K. Melatonin induces γ-glutamylcycsteine synthesis mediated by activator protein-1 in human vascular endothelial cells. Free Radic. Biol. Med. 27:1999;838-847.
42. Abdel-Wahab M.H., Abd-Allah A.R. Possible protective effect of melatonin and/or desferrioxamine against streptozotocin-induced hyperglycemia in mice. Pharmacol. Res. 41:2000;533-537.
43. Reiter R.J., Tan D.X., Osuna C., Gitto E. Actions of melatonin in the reduction of oxidative stress. J. Biomed. Sci. 7:2000;444-458.
44. Haga S., Haga C., Aizawa T., Ikeda K. Neuronal degeneration and glial cell-responses following trimethyltin intoxication in the rat. Acta Neuropathol. 103:2002;575-582.
45. Baydas G., Reiter R.J., Nedzvetskii V.S., Yasar A., Tuzcu M., Ozveren F., Canatan H. Melatonin protects the central nervous system of rats against toluene-containing thinner intoxication by reducing reactive gliosis. Toxicol. Lett. 137:2003;169-174.
46. Kapanoglu E., Palaoglu S., Demirpence E., Akbiyik F., Solarogul I., Kilinc A. Different responsiveness of central nervous system tissues to oxidative conditions and to the antioxidant effect of melatonin. J. Pineal Res. 34:2003;32-35.
47. Martin V., Sainz R.M., Antolin I., Mayo J.C., Herrera F., Rodriguez C. Several antioxidant pathways are involved in astrocyte protection by melatonin. J. Pineal Res. 33:2002;204-212.
48. Menendez-Pelaez A., Poeggeler B., Reiter R.J., Barlow-Walden L., Pablos M.I., Tan D.X. Nuclear localization of melatonin in different mammalian tissues immunocytochemical and radioimmunoassay evidence . J. Cell Biochem. 53:1993;373-382.
49. Baydas G., Gursu M.F., Yilmaz S., Canpolat S., Yasar A., Cikim G., Canatan H. Daily rhythm of glutathione peroxidase activity, lipid peroxidation and glutathione levels in tissues of pinealectomized rats. Neurosci. Lett. 3:2002;195-198.
50. Raps S.P., Lai J.C., Hertz L., Cooper A.J. Glutathione is present in high concentrations in cultured astrocytes but not in cultured neurons. Brain Res. 493:1989;398-401.
51. Savolainen H. Superoxide dismutase and glutathione peroxidase activities in rat brain. Res. Commun. Chem. Pathol. Pharmacol. 21:1978;173-176.
52. Mattson M.P., Cheng B., Baldwin S.A., Smith-Swintosky V.L., Keller J., Geddes J.W., Scheff S.W., Christakos S. Brain injury and tumor necrosis factors induce calbindin D-28k in astrocytes evidence for a cytoprotective response . J. Neurosci. Res. 42:1995;357-370.
53. Donato R. S100 a multigenic family of calcium-modulated proteins of the EF-hand type with intracellular and extracellular functional roles . Int. J. Biochem. Cell Biol. 33:2001;637-668.
54. Vural H., Sabiencu T., Arslan S.O., Aksoy N. Melatonin inhibits lipid peroxidation and stimulates the antioxidant status of diabetic rats. J. Pineal Res. 31:2001;193-198.